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Gene therapy vectors derived from subgroup C adenoviruses of the serotype 5 (Ad5) and 2 (Ad2) resulted in inefficient
infection of well differentiated respiratory cells, both in vitro and in vivo. The level of expression and localization of the
primary receptor for Ad5 and Ad2, termed CAR, do not completely explain why the infection efficiency varies greatly in
different experimental conditions. The possibility that additional receptors like proteoglycans are involved in the infection of
Ad5 and Ad2 was investigated, because several pathogenic microorganisms use heparan sulfate–glycosaminoglycans
(HS-GAGs) as coreceptors for multistep attachment to target cells. The HS-GAG analog heparin decreased Ad5- and
Ad2-mediated infection and binding starting from the concentration of 0.1 mg/ml, up to a maximum of 50%. A similar reduction
in Ad5 binding and infection was obtained by treatment of cells with heparin lyases I, II, and III but not with chondroitin ABC
lyase. The effect of heparin on Ad5 binding has not been observed in surface GAG-defective Raji cells and after treating A549
cells with heparin lyases I, II ,and III. The binding of Ad5 was completely abolished when both CAR was blocked with RmcB
antibody and HS-GAGs were competitively inhibited by heparin. Parallel experiments demonstrate that HS-GAGs are
irrelevant to binding and infection of the subgroup B adenovirus type 3. Collectively, these results demonstrate for the first
time that HS-GAGs expressed on the cell surface are involved in the binding of Ad5 and Ad2 to host cells. © 2000 Academic
Press
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Adenovirus (Ad) is a double-stranded DNA nonenvel-
oped icosahedral virus; on each of the 12 vertices is a
penton, a complex of the penton base anchored in the
capsid and the antenna-like fiber (Horwitz, 1991). Infec-
tion begins with the interaction between the fiber protein
and primary receptor or receptors. After fiber binding, the
Arg-Gly-Asp (RGD) sequence of the penton base inter-
acts with av integrins (Wickham et al., 1993), which trig-
er a dynamin-dependent internalization (Wang et al.,
998), possibly by activation of a phosphoinositide-3-OH-
inase (Li et al., 1998). A primary cellular receptor for the
binding of the fiber of Ads has been identified, being a
42-kDa glycoprotein in common for coxsackie B and Ad
serotype 5 (Ad5) and serotype 2 (Ad2) viruses, termed the
coxsackievirus and adenovirus receptor (CAR) (Bergel-
son et al., 1997, 1998; Tomko et al., 1997). It has been
ecently demonstrated that at least seven additional Ad
erotypes can use CAR as a cellular fiber receptor
Roelvink et al., 1998). HLA class I molecules may also
articipate in Ad5 fiber binding on the cell surface (Hong
t al., 1997; Davison et al., 1999).
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382Replication-defective Ad5 and Ad2 have been widely
studied as DNA vectors for gene therapy in human dis-
eases (Smith, 1998), including the correction of the ge-
netic defect of cystic fibrosis in respiratory cells (Rosen-
feld et al., 1992). A major problem raised by the applica-
tion of these vectors in cystic fibrosis lung gene therapy
is the low efficiency of gene transfer in well differentiated
airway cells (for a review, see Boucher, 1999). It has been
demonstrated that a determining factor for inefficiency in
polarized respiratory cells is the localization of the CAR
receptor and av integrins on the basolateral membrane
(Pickles et al., 1998; Walters et al., 1999), which is
scarcely accessible to vectors deposed on the luminal
side of the airway tract. In addition, studies using non-
polarized airway cells demonstrated that the efficiency of
gene transfer is much higher in cells in regeneration,
which implies spreading, migration, and dedifferentiation
(Dupuit et al., 1995, 1997). Several possibilities could be
taken into consideration to explain the latter observation.
CAR expression in respiratory cells may decrease in well
differentiated cells, as reported for skeletal muscle (Nal-
bantoglu et al., 1999). Moreover, regenerating cells may
express or upmodulate additional receptor or receptors
besides CAR, increasing the efficiency of attachment and
infection of Ad5 and Ad2.Glycosaminoglycans (GAGs) are long polyanionic car-
bohydrate chains consisting of repeating disaccharide
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383Ad5 AND Ad2 AND HS GLYCOSAMINOGLYCANSunits containing sulfate residues. Sulfate content and
charge density vary among the disaccharide repeats of
the most common GAGs. GAGs covalently linked to a
protein core are termed proteoglycans (PG), which are
widely expressed on cell surfaces and in intracellular
secretion granules and extracellular matrix (Hassel et al.,
1986; Poole, 1986). PGs are involved in several important
functions, including blood coagulation (Bourin and Lin-
dahl, 1993), the modulation of growth factor activities
(Ruoslahti and Yamaguchi, 1991), cell attachment, prolif-
eration, migration, morphogenesis, and receptor-medi-
ated endocytosis (Ho et al., 1997; Poole, 1986). Several
pathogenic microorganisms (e.g., bacteria, parasites, vi-
ruses) have learned to exploit the cell-surface PGs as
coreceptors for attachment (Rostand and Esko, 1997),
sometimes with complex multistep infection process, as
described for some viruses (WuDunn and Spear, 1989;
Shieh et al., 1992). For instance, heparan sulfate (HS)-
PGs play a role together with human fibroblast growth
factor receptor (FGFR) and avb5 integrins in the infection
f type 2 adeno-associated parvoviruses (AAV) (Summer-
ord and Samulski, 1998; Qing et al., 1999; Summerford et
l., 1999). On this basis, we investigated the possibility of
ell-surface PGs taking part in the infection of Ad5 and
d2.
RESULTS
ffect of heparin on infection efficiency
Heparin is often used experimentally as an HS analog,
hus inhibition of infection by heparin was investigated
irst to explore whether GAGs are used for viral attach-
ent. Ad5- and Ad2-mediated infection of A549 cells was
educed by heparin, as shown in Fig. 1. Concentrations
tarting from 0.1 mg/ml decreased infection up to 50%. No
urther inhibition was observed at higher concentrations,
p to 1 mg/ml (not shown). The same experiment was
erformed with Ad3, which is known to use an uniden-
ified primary receptor different than CAR (Roelvink et al.,
998). As reported in Fig. 1, heparin had no inhibitory
ffect on Ad3-mediated infection, even at concentrations
igher than those shown (1 mg/ml). These results indi-
ate that heparin competes with cellular receptors in the
nfection process of Ad5 and Ad2, but not Ad3, suggest-
ng a participation of cell-surface HS-GAGs.
odulation of infectivity by enzyme treatment of cell-
urface GAGs
If infection is modulated by cell-surface GAGs, enzy-
atic digestion of those most commonly expressed on
ell membranes, namely HSs and chondroitin sulfates
Rostand and Esko, 1997), should decrease infectivity.
ells were incubated with Hep3 (a mixture of heparinyase I, EC 4.2.2.7; heparin lyase II, no EC number;
eparin lyase III, EC 4.2.2.8; Liu et al., 1997), which
a
tleaves heparin and HS, or chondroitin ABC lyase, which
leaves chondroitin sulfates A, B, and C. Figure 2A
hows that digestion with Hep3, but not chondroitin ABC
yase, reduced Ad5-mediated infection by 50% on A549
ells. Neither Hep3 nor chondroitin ABC lyase decreased
d3 infection. Because the contamination of lyases with
roteases may reduce cell-surface CAR, its expression
as checked by immunocytochemistry under the same
xperimental conditions (Figs. 2C–2E). As shown in Fig.
D, Hep3 treatment of A549 cells did not reduce CAR
xpression. The effect of Hep3 was not restricted to A549
ells, as similar results were obtained with HeLa cells
Fig. 2B), which are widely used together with A549 cells
s a cell model for Ad basic biology studies. These
esults indicate that HS moiety of GAGs expressed on
ell surface intervenes in Ad5-mediated infection.
ompetitive inhibition of binding with soluble heparin
The involvement of HS-GAGs could be related to dif-
erent steps of the infection process, starting from the
inding of the virus to host cell receptors. [3H]Ad binding
as measured in the presence of different concentra-
ions of soluble heparin. As shown in Fig. 3, heparin
educes Ad5 and Ad2 binding to a residual 40–50%
tarting from the concentration of 0.1 mg/ml, consistent
ith the effect observed on infection. Ad3 binding was
ot significantly inhibited by heparin. Therefore heparin
FIG. 1. Soluble heparin inhibits infection of Ad5 and Ad2 in A549
cells. Effect of heparin on infection mediated by Ad5, Ad2, and Ad3.
Viruses were preincubated with heparin for 1 h at 37°C. The foci
counted in the absence of heparin were 1598 6 166 for Ad2, 1549 6 13
for Ad3, and 1275 6 29 for Ad5 per well (mean 6 SD). Values are
representative of at least five independent experiments.ffects Ad5 and Ad2 infection by reducing the binding to
he host cell, as demonstrated in Fig. 3.
H nt exp
t ibody. (
384 DECHECCHI ET AL.Ad binding after enzymatic treatment of surface
GAGs
[3H]Ad binding was measured after enzymatic treat-
ment of HS-GAGs expressed on cell surface, as we
observed that HS-GAGs participate in Ad5 infection. Be-
fore binding, A549 cells were preincubated either with
Hep3 or chondroitin ABC lyase. In parallel, viruses were
preincubated with or without 10 mg/ml soluble heparin to
FIG. 2. Hep3 reduces infection of Ad5. A549 (A) and HeLa cells (B) we
(10 U/ml, for 90 min at 30°C), infected with Ad5 or Ad3, and analyzed b
the number of fluorescent foci in wells in which lyase digestion was o
samples of the reported experiments were 1398 6 195 for Ad3 and 75
eLa cells (mean 6 SD). Values are representative of three independe
reatment in the presence (C) or absence (E) of the primary RmcB antconfirm that heparin-sensitive binding is dependent on
cell-surface HS-GAG expression. Hep3, but not chon-droitin ABC lyase, reduces the binding of Ad5 to cells, in
analogy to the effect observed on infection, as reported
in Fig. 4A (open columns). As expected from the previous
results, Fig. 4B shows that enzyme treatment did not
reduce significantly the binding of Ad3, confirming that
HS-GAGs are not involved in Ad3 binding. Moreover,
soluble heparin did not decrease the extent of binding of
Ad5 to cells treated with Hep3, indicating that heparin
competes with cell-surface HS-GAGs. These results in-
ed with Hep3 (filled columns) or chondroitin ABC lyase (open columns)
scent focus assay. Percent inhibition of infectivity was calculated from
(control samples). The fluorescent foci per well counted in the control
for Ad5 in A549 cells and 552 6 68 for Ad3 and 624 6 102 for Ad5 in
eriments. CAR expression by APAAP system. A549 cells without lyase
D) A549 cells treated with Hep3. Bar corresponds to ;20 mm.re treat
y fluore
mitted
6 6 17dicate that Ad5 binding involves HS-GAGs expressed on
the surface of A549 cells.
Vp
385Ad5 AND Ad2 AND HS GLYCOSAMINOGLYCANSEffect of anti-CAR antibody on binding and infection
It should be recalled that CAR has been already iden-
tified as a primary receptor for Ad5 and that both heparin
and heparin lyases do not completely inhibit the binding
and infection of Ad5. Therefore, we investigated the ef-
FIG. 3. Heparin reduces binding of Ad5 and Ad2 to A549 cells. Effect
of heparin on binding mediated by Ad5, Ad2, and Ad3. [3H]Ads were
preincubated with heparin for 1 h at 37°C, and binding to cells was
performed for 1 h at 4°C. Ad bound to A549 cells in the absence of
heparin [(cpm of virus bound/cpm of total virus added) 3 100] was
4.2 6 0.6 (Ad2), 12.3 6 0.9 (Ad3), and 5.4 6 0.2 (Ad5) (mean 6 SD).
alues are representative of at least five independent experiments.
FIG. 4. Hep3 reduces binding of Ad5 to A549 cells. [3H]Ad5 (A) and [3retreated with Hep3 or chondroitin ABC lyase (10 U/ml, for 90 min at 30°C) b
total virus added. Values are representative of three independent experimentfect of blockage of CAR on Ad5 binding and infection.
Coxsackie B and Ad2 and Ad5 receptor was immunoaf-
finity purified from HeLa cells with the monoclonal anti-
body RmcB, which inhibits the binding and infection of
coxsackie B virus (Hsu et al., 1988; Bergelson et al.,
1997). As reported in Fig. 5 (inset), under our experimen-
tal conditions, preincubation of A549 cells with RmcB
(kindly donated by Dr. Robert W. Finberg) inhibited bind-
ing of both Ad2 and Ad5 but not Ad3 (which does not
recognize CAR). As shown in Fig. 5, neither RmcB nor
heparin inhibited the binding of Ad5 completely. Interest-
ingly, preincubation of both RmcB with cells and heparin
with virus totally abolished the binding of Ad5 to A549
cells. The effect of RmcB and heparin was also tested in
infection experiments. The results reported in Fig. 6 con-
firm the additive effect observed in binding experiments
when heparin and RmcB were added together. The pres-
ence of a residual infectivity could be explained by entry
of the virus by receptor-independent fluid phase pinocy-
tosis, as demonstrated with fluorescent Ads in A549 cells
(Leopold et al., 1998). Another explanation might relate to
temperature, because binding studies were carried out
entirely in the cold, whereas the cells had to be warmed
for the infectivity experiments. To further investigate the
relationship between CAR and HS-GAGs, binding exper-
iments were performed in HS-GAG-defective Raji cells
(Mounkes et al., 1998), which express CAR (David Curiel,
personal communication). The results reported in Figure
7 show that RmcB fully inhibited Ad5 binding to Raji cells,
also making it unlikely that the partial inhibition observed
in A549 cells is due to a low blocking efficiency of the
B) were preincubated with or without 10 mg/ml heparin, and cells were
3H]Ad3 (
efore binding assay. The [ H]Ad bound reported is the percent of the
s.
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386 DECHECCHI ET AL.antibody (see Fig. 5). In parallel, Fig. 7 also shows that
soluble heparin does not affect Ad5 binding to the HS-
GAG-defective Raji cell line, as expected. Taken together,
FIG. 5. Additive inhibition of binding of Ad5 by RmcB and heparin.
549 cells were preincubated with RmcB (1:100 dilution in PBS11) for
1 h at 4°C and washed before binding. [3H]Ad5 was preincubated with
0 mg/ml heparin for 1 h at 37°C. Values are representative of four
independent experiments. Ad bound to A549 cells in the absence of
heparin and RmcB [(cpm of virus bound/cpm of total virus added) 3
100] was 4.7 6 1.1 (mean 6 SD). (Inset) Effect of RmcB on the binding
of [3H]Ad2, [3H]Ad3, and [3H]Ad5 to A549 cells, as described above. Ad
ound to A549 cells in the absence of RmcB [(cpm of virus bound/cpm
f total virus added) 3 100] was 4.8 6 1.8 for Ad2, 9.9 6 3.5 for Ad3, and
.0 6 1.2 for Ad5 (mean 6 SD). Values are representative of four
ndependent experiments.
FIG. 6. Additive inhibition of infection of Ad5 by RmcB and heparin.
mcB and heparin were preincubated before infection as described in
he legend to Fig. 5. Infection was performed as described in the
egend to Fig. 1. The foci counted in the control sample were 955 6 10per well (mean 6 SD). Values are representative of four independent
experiments.these results suggest that the presence of cell-surface
HS-GAGs increases the efficiency of Ad5 binding to host
cells expressing CAR.
DISCUSSION
Our results demonstrate for the first time that HS-
GAGs expressed on cell surface are involved in the
binding of Ad5 and Ad2, based on the following evi-
dence: (1) binding and infection are competitively inhib-
ited by heparin, a soluble receptor analog; (2) cleavage
of cell-surface HS-GAGs, but not chondroitin sulfate
GAGs, inhibits the binding and infection; and (3) heparin
does not inhibit the binding of Ad5 after cleavage of
HS-GAGs in A549 cells and in GAG-defective Raji cells.
Introducing a hepta-lysine sequence into the C-termi-
nus of the fiber gene of Ad5, Wickham and colleagues
increased the efficiency of infection of cells expressing
low levels of the primary receptor, and this effect was
abolished by heparin (Wickham et al., 1996, 1997). On the
parental virus, the addition of heparin to cells had vari-
able effects, both increasing and decreasing the binding
(Wickham et al., 1997). In reference to our results, it
should be noted that the experimental design is very
different. The addition of the hepta-lysine sequence into
the fiber knob could interfere with the binding to the
primary receptor. Moreover, Wickham and colleagues
preincubated heparin with cells and not with the parental
virus, which is a critical condition to obtain the results
reported here.
From the present results, we cannot say which viral
structure interacts with cell HS-GAGs. From a survey of
a number of heparin-binding proteins, two major consen-
FIG. 7. Effect of RmcB on the binding of Ad5 to Raji cells. Raji cells
were preincubated with RmcB or mouse IgG (20 mg/ml each) for 1 h at
4°C and washed before binding. [3H]Ad5 was preincubated with 10
mg/ml heparin for 1 h at 37°C and added to Raji cells for 1 h at 4°C. The
[3H]Ad bound reported is the percent of the total virus added. Values
are representative of three independent experiments.sus sequences for interactions with GAGs have been
proposed: BBXB and BBBXXB, where B is a basic amino
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387Ad5 AND Ad2 AND HS GLYCOSAMINOGLYCANSacid (Templeton, 1992). A candidate linear heparin-bind-
ing sequence of the BBXB model is contained in the third
pseudorepeat of the fiber shaft of Ad5 and Ad2 but not
Ad3 (residues 91–94, sequence KKTK), which is close to
the penton base and far from the C-terminal knob. It
should be recalled that the full-length of the Ad5/2 fiber
is approximately 37 nm (Chroboczek et al., 1995) and that
the HS chains may form an extended linear polymer of an
estimated length of up to 60 nm (Carey, 1997). From this
point of view, it seems plausible that HS-PGs could
interact with the third pseudorepeat of the fiber shaft. A
recent study suggests that this sequence could be lo-
cated at the periphery of the hydrophobic core of the Ad2
fiber shaft (van Raalj et al., 1999); whether these basic
esidues are actually available to HS-GAG binding will
equire further investigation. Besides the linear se-
uences that can be inferred from primary protein struc-
ure, GAG-binding motifs can be predicted by defining
ultiple regions separated by turns that bring these
asic amino acid regions into apposition (Chen et al.,
997). In this respect, other nonlinear sequences of the
d5/2 capsid could be involved in the HS-PG interac-
ions.
The experiments reported here show that Ad5 binding
as completely abolished only when RmcB antibody
as used together with heparin in A549 cells, which
xpress both CAR and HS-PGs. Second, Ad5 binding
as fully blocked by RmcB in cells expressing CAR but
acking HS-PGs, like Raji cells. These results confirm
hat CAR is sufficient for Ad5 binding. On the other side,
s widely reported by others, Ad5 and Ad2 are not able
o bind to CAR-defective Chinese hamster ovary (CHO)
ells, which express HS-GAGs, indicating that HS-PGs
re not sufficient alone for Ad5 binding (Bergelson et al.,
997; Roelvink et al., 1998; Davison et al., 1999). That
S-GAGs alone are not sufficient for Ad5 binding to host
ells is not necessarily contradictory with the data re-
orted here demonstrating that HS-PGs increase the
inding efficiency of Ad5 and Ad2 to CAR-expressing
ells. Similar scenarios have already emerged for the
inding of other viruses, like type 2 AAVs, which use
GFR, HS-PGs, and avb5 integrins for viral entry (Sum-
erford and Samulski, 1998; Qing et al., 1999; Summer-
ord et al., 1999). In fact, HS-PGs cooperate with FGFR
ut are insufficient alone for AAV binding, as observed in
ecombinant Raji cells expressing HS-PGs but not the
GFR (Qing et al., 1999). Interesting suggestions can be
lso obtained from coxsackie virus B3 (CVB3), which
ecognizes both CAR and the decay-accelerating factor
DAF) as attachment sites (Shafren et al., 1995, 1997).
CAR is sufficient alone for CVB3 binding, as demon-
strated in DAF-defective recombinant CHO cells ex-
pressing CAR (Bergelson et al., 1997). Second, DAF is
insufficient alone for CVB3 binding, as shown in CAR-
defective recombinant CHO cells expressing DAF (Ber-
w
Mgelson et al., 1995). Third, the presence of monoclonal
antibodies to both CAR and DAF is necessary to obtain
total inhibition of binding and lytic infection in cells ex-
pressing both CAR and DAF (Shafren et al., 1995). There-
fore, DAF has been proposed as a CVB3 sequestration
site enhancing viral presentation to CAR (Shafren et al.,
1995). All this considered, in light of our findings, we
propose that HS-GAGs are cooperative receptors for Ad5
and Ad2 by increasing the efficiency of the binding and
infection mediated by CAR. The exact mechanism of this
interaction requires further investigation. In general, dif-
ferent mechanisms have been proposed to explain the
cooperative role of HS-GAGs. They may bring the viruses
in closer proximity to the membrane, to facilitate the
binding to other receptors (Haywood, 1994). Furthermore,
they may strengthen the binding by clustering or stabi-
lizing other receptors (Carey, 1997). Again, the density of
HS-PGs on cell surface could influence the probability of
a weakly bound virus interacting with a second receptor
(Summerford et al., 1999).
The use of Ad5- and Ad2-derived vectors for gene
transfer in respiratory cells in vivo and in vitro has pro-
vided important feedback information on the basic biol-
ogy of Ads and their normal mechanism of infection. For
instance, the apical membrane of polarized well differ-
entiated respiratory cells represents a barrier for Ad5-
and Ad2-derived vectors, which infect efficiently only
through the basolateral side, where CAR and av integrins
xpression is restricted (Pickles et al., 1998; Walters et
l., 1999). In reference to the data reported here, it is
oteworthy to recall that HS-GAGs also are known to be
xpressed on the basolateral, but not apical, membrane
f polarized respiratory cells in vivo (Carey, 1997; Duan et
l., 1998). Experiments in vitro demonstrated that airway-
egenerating cells are preferential targets for gene trans-
er by Ad5-derived vectors (Dupuit et al., 1995, 1997).
ecause PGs expression is modulated in proliferating
nd migrating cells (Wight et al., 1992), it will be worth
nvestigating whether HS-GAG expression can provide
seful hints to explain the increased infection efficiency
f Ad-derived gene therapy vectors observed in regen-
rating cells.
MATERIALS AND METHODS
ell lines
Human alveolar type II-derived carcinoma A549 cells,
eLa cells, and human lymphoblastoid Raji cells were
btained from the American Type Culture Collection
ATCC; Manassas, VA). The tissue culture medium was
ulbecco’s modified Eagle’s medium (DMEM) (A549 and
eLa cells) or RPMI medium (Raji cells), supplemented
ith 10% fetal bovine serum (BioWhittaker, Walkersville,
D).
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388 DECHECCHI ET AL.Viruses
Ad2, Ad3, and Ad5 were obtained as stocks from ATCC
and passaged on A549 cells. The viruses were purified
from infected cells by four freeze–thaw cycles, followed
by two successive bandings on CsCl gradients accord-
ing to Precious and Russell (1995). Purified viruses were
dialyzed against 10 mM Tris–HCl (pH 7.4) and 1 mM
MgCl2. The dialysate was aliquoted with the addition of
0% glycerol and stored at 280°C until use. The concen-
tration of purified Ad was determined on absorbance
measured at 260 nm according to Mittereder et al. (1996),
who assumed the conversion factor of 1 OD unit of Ad5
corresponding to 1.1 3 1012 virions.
ell infection assay
The adenovirus infection was quantified as described
y Wickham et al. (1993) with the following modifications.
549 or HeLa cells were seeded onto chamber slides
nd left to reach confluence to provide standard surface
rea. For competition experiments, viruses were prein-
ubated with heparin (from porcine intestine; Sigma
hemical Co., St. Louis, MO) in DMEM plus 0.1% BSA for
h. Preliminary experiments had shown that preincuba-
ion at 4°C gave the same results as that at 37°C but
ook longer to reach equilibrium. We therefore performed
ll incubations at 37°C. Virus was then added to cells for
h at 4°C, at dilutions previously determined to generate
tatistically reliable numbers of foci. The inoculum was
emoved, and the wells were washed twice with cold
MEM before incubating cells with tissue culture me-
ium for 24 h at 37°C. Infected monolayers were fixed
ith acetone for 10 min, allowed to dry, and then blocked
ith 10% pig serum in PBS for 30 min. Anti-Ad primary
ntibody directed against hexon protein (Bio-Science
roducts AG, Emmenbrucke, Switzerland) was used in a
ilution of 1:100 in 10% pig serum and incubated for 1 h.
fter washing, cells were incubated for 30 min with a
:100 dilution of fluorescein isothiocyanate-conjugated
abbit anti-mouse antibody (Sigma Chemical Co.) in 1%
vans blue in PBS. Slides were then washed and
ounted, and fluorescent foci were counted with a Nikon
MD inverted microscope. Infectivity was calculated as
he percentage of infected foci in the experimental sam-
le divided by the number of infected foci in the control
ample.
methyl-3H]Thymidine Ad labeling and binding assay
This was carried out according to Roelvink et al.
(1996). Briefly, 24 h after Ad infection, confluent A549
cells were incubated with 0.5 mCi [methyl-3H]thymidine
(Amersham Inc., Arlington Heights, IL) in 10 ml of me-
dium (75-cm2 surface). After overnight incubation, 15 mlf fresh medium was added. Cells were harvested 2–3
ays postinfection, and virus was purified as describedefore. Specific radioactivity ranged between 4 3 1025
and 9 3 1024 cpm/virion particle. For binding assay,
confluent A549 cells detached with 5 mM EGTA in PBS or
Raji cells were suspended at the concentration of 4 3
106/ml in PBS11 (PBS, 3 mM MgCl2, 1 mM CaCl2). Ra-
dioactive Ads (15,000–20,000 cpm) were incubated for
1 h at 4°C with 1 3 106 cells in Eppendorf tubes pre-
oated with 5% BSA in PBS11. Cells were washed twice
ith PBS11, and the pellet was suspended in 100 ml of
PBS11 and placed in a liquid scintillation counter. The
ercent [3H]Ad bound reported in the figures refers to the
Ad bound in the control samples of each experiment
normalized to 100%. Specific binding was calculated by
subtracting the signal obtained in the presence of 50-fold
excess nonlabeled Ad. The average nonspecific binding
was 20% of the total Ad bound. Competition experiments
with heparin were performed as described in the infec-
tion assay.
GAG lyases treatment
To remove GAGs from cell surface, cells were incu-
bated for 90 min at 30°C with 10 U/ml Hep3 (Liu et al.,
997) or chondroitin ABC lyase (EC 4.2.2.4) (Sigma
hemical Co.) dissolved in PBS containing 1 mM CaCl2,
.5 mM MgCl2, 1 mg/ml glucose, 1% FBS, and the pro-
ease inhibitors phenylmethylsulfonyl fluoride (100 mM)
nd leupeptin (20 mM). Cells were then washed with
ce-cold PBS and processed for infection or binding as-
ays as described.
AR expression by immunocytochemistry
CAR expression was checked with RmcB monoclonal
ntibody (Hsu et al., 1988) (ascites form), a generous gift
f Dr. Robert W. Finberg (Dana-Farber Cancer Institute,
oston, MA). A549 cells were seeded onto chamber
lides and treated with lyases as described for cell
nfection assay. Cells were fixed with 4% formaldehyde
or 10 min at 4°C, washed with PBS solution, overcoated
ith 3% BSA, and incubated with RmcB (1:100) for 1 h at
oom temperature. Primary antibody recognition was de-
ected by using the alkaline phosphatase–monoclonal
nti-alkaline phosphatase system (Cordell et al., 1984).
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